CDC Logo Link to CDC Link to Public Health Emergency Preparedness & Response
Link to "Normal Reactions" Page Link to "Adverse Reactions" Page All Reactions Pull-Down Menu Link to "Site Map" Page
Link to "Home" Page
Link to "Smallpox" Page
Deselected Link to "About the Vaccine" Page
Link to "Contraindications" Page
Link to "Vaccination Method" Page
Link to "Preventing Contact Transmission" Page
Link to "Vaccinia Immune Globulin" Page
Link to "Laboratory Testing" Page
Link to "Contact" Page
Copyright of CDC/HHS

About the Vaccine: Emergency Vaccination

Image of Links for the "About the Vaccine"  Pages

Post-Exposure Vaccination
Epidemiological evidence indicates that vaccination within 2-3 days after exposure to smallpox can result in protection against the disease and, even as late as 4 to 5 days, may protect against a fatal outcome.

Vaccine Availability
In the event of a smallpox attack prior to the availability of tissue cell-culture vaccine, sufficient amounts of calf-lymph vaccine are available from CDC. The calf-lymph vaccine (Dryvax/Wyeth) was prepared and lyophilized in the 1970’s, but has recently been tested for viability and found to be potent at a 1/5 dilution. It is stored in 500 dose vials.

A similar calf-lymph vaccine preparation produced by Aventis-Pasteur in the 1950's has also been tested recently and found to be fully potent. It is available as a virus suspension in a glycerinated diluent. It is stored in 100 dose vials. The technique of administration is exactly as described for the tissue cell culture vaccine on the Vaccination Method page.

Emergency Vaccination Strategy
If smallpox occurs, priority will be given to
• Early diagnosis of cases
• All those who had been in contact with the
   patient since onset of fever
• All household members of the contacts

This is called surveillance and containment; some call it "ring vaccination."

The ring vaccination has two functions. Even if the vaccine is given too late for this primary protection and the contact develops smallpox, vaccination of his household contacts will serve to provide a barrier of immunity to prevent further spread.

The strategy was successfully employed in the eradication effort. It is based on the fact that the infected individual does not transmit infection until he first develops a rash. Preceding the rash is a prodrome marked by severe systemic illness with high fever. Most patients are too ill to move about during this period and stay in bed. Thus, most secondary transmission occurs either in the home or in the hospital. Should the number of cases warrant it, community-wide vaccination may be used to supplement the surveillance-containment strategy.

Link to "About the Vaccine" Page Link to "About the Vaccine: In-depth Vaccine Information" Page Link to "About the Vaccine: Immunity Against Smallpox" Page Link to "About the Vaccine: References" Page Link to CDC